Skip Ribbon Commands
Skip to main content
Disease Page

Hepatocellular carcinoma (HCC)

Other diseases:


Terumo provides a wide choice of products in Interventional Oncology for the treatment of HCC, an aggressive liver malignancy that is the 6th leading cancer in the world by incidence and often occurs in the setting of chronic liver disease and cirrhosis.
Find out more about how Terumo can support you in the treatment of HCC.

Curative treatment

For Very early stage (0) and Early stage (A) HCC, Terumo offers ablation for curative treatment. (BCLC; HCC Guidelines 2017) 1

Find out more about BCLC:


Palliative treatment

For Intermediate stage (B), Advanced stage (C), Terumo offers chemoembalisation (BCLC; HCC Guidelines 2017) 1 and radioembolization for palliative treatment.

Chemoembolization (TACE)

Radioembolization (SIRT)

Find out more about our wide choice of products that can support you in the treatment of HCC.

Lifepearl loaded with doxorubicin in a patient with HCC pre-transplant

Nuno Vasco Costa, MD

55 years old male with alcoholic/hepatitis C virus related cirrhosis (abstinent in the last 10 years) and elevated serum liver enzymes (ALT, AST, ALP, GGT) with a Child-Pugh score of 6 points (A).

Lifepearl loaded with doxorubicin - downstage a patient with HCC to reach liver transplant

Nuno Vasco Costa, MD

67 years old male with alcoholic related cirrhosis (abstinent in the last 2 years) and negative HBs antigen and anti-HCV antibody. An elevated level of serum liver enzymes...

Y90 SIRT with Occlusafe Micro-Balloon Catheter infusion system in a patient with unresectable HCC: the right way

Giulio Eugenio Vallati MD

A 67-years-old man with no history of liver disease presented with 4 months of abdominal pain and weight loss. Abdominal CT showed a large hepatic lesion in the left lobe...

SIRT with Occlusafe in unresectable HCC, portal vein thrombosis and high-flow fistula

Giulio Eugenio Vallati MD

An 80-years-old man with history of cirrhosis (HCV+) affected by progressive weight loss and high AFP level. Abdominal CT showed a massive hepatic lesion in the right lobe...

Successful Balloon-Occluded DEB-TACE after failure of SIRT and DEB-TACE

Illario Tancredi, MD; Gontran Verset, MD

A large hepatocellular carcinoma (HCC) in the right liver lobe was diagnosed in a 66-year old patient affected by a Child A alcoholic cirrhosis. Due to the large size of the lesion a radioembolization (SIRT) was performed. But disease ...

Balloon-Occluded DEB-TACE for a single node HCC as bridge to transplantation

Gontran Verset, MD; Illario, Tancredi, MD

A single 35 mm hepatocellular carcinoma (HCC) located in hepatic segment VI was diagnosed in a Child A cirrhotic patient. This 57 years-old patient was infected by...

QuiremSpheres® treatment of a 77-year-old male patient with hepatocellular carcinoma

Prof. Dr. Ralf-Thorsten Hoffmann (IR) and Dr. Klaus Zoephel (NM)

A 77-year-old male patient with a history of hepatocellular carcinoma (HCC) was first diagnosed with large HCC...

Safe microwave ablation of liver cancer in an elderly patient

Roberto Chiavaroli MD

CF, 86-year-old man with HBV infection and liver cirrhosis (CHILD A5, MELD score 7- oesophageal varices Fo) with unifocal HCC 26 mm in size in the right lobe (VIII liver segment) detected by contrast...

Single nodular recurrence on the left liver lobe after previous right hepatectomy: treatment with TATO

Dr. Pablo Navarro Vergara

Man 55 years old with cirrhosis and HCV. Patient with previous right hepatectomy due to hepatocarcinoma (HCC) presenting a single nodular recurrence of 3 cm in the left lobe.

A 2 cm lesion MW ablation treatment

Dr. Pablo Navarro Vergara

Woman 76 years old with cirrhosis and HCV. Presents an hepatic LOE in segment VII of 2 cm of diameter in which is performed ablation with TATO ablation device.

HCC MW ablation with 2 antennas using navigation system

Hans Martin Gissler, MD

In a female patient 68 yrs. old with liver cirrhosis Child A MRI was suspicious for hepatocellular carcinoma segment VIII of 2 cm of diameter in the liver dome (Fig. 1). Tumor board transferred her to ablation.

More case studies



Data on file. Terumo's products linked to BCLC Guidelines for hepatocellular carcinoma treatment as of 2017.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public

For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.